Related by context. Frequent words. (Click for all words.) 67 Galapagos NV Euronext GLPG 66 Group NV Pharming 64 NASDAQ CRXL 63 Inc. Nasdaq SEPR 63 NASDAQ NYMX 63 Inc. NASDAQ MRNA 62 Iomai Corporation 62 Actelion Ltd 62 Crucell NV Euronext 62 Celsion Corporation 62 Nasdaq VRTX 61 Dynavax Technologies Corporation 61 NASDAQ LGND 61 Company NASDAQ MDCO 61 OctoPlus 61 Idera Pharmaceuticals 60 Exchange CRX 60 TSX AEZ 60 NASDAQ IMCL 60 NASDAQ ARIA 60 NASDAQ SHPGY 60 NASDAQ CYPB 60 China Aoxing Pharmaceutical 60 BioSilicon TM 59 Inc. Nasdaq DSCO 59 Response Biomedical Corporation 59 Emisphere Technologies 59 Merck Serono division 59 www.patheon.com 59 Sciele Pharma Inc. 59 Nasdaq REGN 59 Nasdaq BDSI 59 Inc Therapeutic Competitors 59 ImmunoGen Inc. 59 Nymox Pharmaceutical Corporation 58 NASDAQ BRKR 58 RegeneRx Biopharmaceuticals Inc. 58 Standard QIA 58 Kiadis Pharma 58 Tranzyme Pharma 58 NASDAQ OSIR 58 MGI PHARMA INC. 58 MiddleBrook Pharmaceuticals Inc. 58 Inc. NASDAQ CRIS 58 Inc. NASDAQ CLDA 58 Chemokine Therapeutics 58 Inc. Nasdaq NVAX 58 immunotherapeutics 57 AEterna Zentaris Inc. 57 NASDAQ DYAX 57 Lipid Sciences Inc. 57 ARYx Therapeutics Inc. 57 SCHWARZ PHARMA 57 Connetics Corporation 57 Atrigel 57 Harbor BioSciences 57 REVLIMID lenalidomide 57 NOXXON 57 ImmuneRegen BioSciences Inc. 57 poorly soluble 57 Response Genetics Inc. 57 NYSE PRX 57 Theratechnologies TSX TH 57 Inovio Biomedical Corporation 57 BioSpecifics Technologies Corp. 57 Onalta 57 Rebif ® 56 Inc. Nasdaq MYL 56 Akorn Inc. 56 ATL# [001] 56 Adeona Pharmaceuticals Inc. 56 Barrier Therapeutics Inc. 56 transdermal delivery 56 HCV protease inhibitor 56 EPIX Pharmaceuticals Inc. 56 PRNewswire FirstCall Novavax 56 commercializing therapeutic 56 Nautilus Biotech 56 Nanobac Pharmaceuticals Inc. 56 Callisto Pharmaceuticals Inc. 56 Application MAA 56 GlaxoSmithKline plc GSK 56 OncoGenex Pharmaceuticals Inc. 56 SCYNEXIS 56 antisense drug 56 Helsinn 56 Anika Therapeutics Inc. 56 Adherex Technologies Inc. 56 Orexo 56 Regado Biosciences 56 Guanilib 56 NanoViricides Inc. 56 Shire plc LSE SHP 55 Novelos Therapeutics Inc. 55 dronabinol 55 novel antibody therapeutics 55 Neurogen Corporation 55 Phase III Clinical Trial 55 Aloxi R 55 therapies Biogen Idec 55 AEterna